Cause-specific excess mortality among dialysis patients: Comparison with the general population in Japan

Therapeutic Apheresis and Dialysis

Volumn 17, Issue 3, 2013, Pages 298-304

  Wakasugi, Minako ^a   Kazama, Junichiro James ^c   Yamamoto, Suguru ^b   Kawamura, Kazuko ^b   Narita, Ichiei ^b  

^a Center for Inter organ Communication Research   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Dialysis; Excess mortality; General population; Standardized mortality ratio

Indexed keywords

ARTICLE; BLEEDING; CACHEXIA; CEREBROVASCULAR ACCIDENT; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS PATIENT; HEPATITIS; HUMAN; HYPERKALEMIA; ILEUS; INFECTION; LIFE EXPECTANCY; LIVER CIRRHOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; QUESTIONNAIRE; SUDDEN DEATH; UREMIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; JAPAN; LIFE EXPECTANCY; MIDDLE AGED; REGISTRIES; RENAL DIALYSIS; VITAL STATISTICS; YOUNG ADULT;

EID: 84878704630     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2012.01144.x     Document Type: Article

References (25)

1. Nakai S, Suzuki K, Masakane I etal. An overview of regular dialysis treatment in Japan (As of 31 December 2008). Ther Apher Dial 2010;14:505-40.
2. Nakai S, Masakane I, Akiba T etal. Overview of regular dialysis treatment in Japan (as of 31 December 2005). Ther Apher Dial 2007;11:411-41.
3. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-19.
4. de Jager DJ, Grootendorst DC, Jager KJ etal. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782-9.
5. World Health Organization. World Health Statistics 2009. Genova: World Health Organization, 2009.
6. Yoshino M, Kuhlmann MK, Kotanko P etal. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 2006;17:3510-19.
7. Patient Registration Committee. In: Tsubakihara Y, ed. An Overview of Regular Dialysis Treatment in Japan as of Dec. 31, 2009 CD-ROM. Tokyo: Japanese Society for Dialysis Therapy, 2010; Tables 123 and 2676.
8. Patient Registration Committee. In: Tsubakihara Y, ed. An Overview of Regular Dialysis Treatment in Japan As of Dec. 31, 2008 CD-ROM. Tokyo: Japanese Society for Dialysis Therapy, 2009; Tables 115 and 102.
9. Bureau of Census, Ministry of Internal Affairs and Communications. Vital Statistics of Japan. 2009. [Accessed 23 Jul 2011.] Available from URL: http://www.e-stat.go.jp/SG1/estat/GL08020103.do?_toGL08020103_&listID=000001057801&disp=Other&requestSender=dsearch
10. Bureau of Census, Ministry of Internal Affairs and Communications. Vital Statistics of Japan. 2009. [Accessed 23 Jul 2011.] Available from URL: http://www.e-stat.go.jp/SG1/estat/GL08020103.do?_toGL08020103_&listID=000001066499&disp=Other&requestSender=dsearch
11. Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan. An Overview of Regular Dialysis Treatment in Japan as of 31 December 2003. Ther Apher Dial 2005;9:431-58.
12. Wakasugi M, Kawamura K, Yamamoto S etal. High mortality rate of infectious diseases among dialysis patients: a comparison with the general population in Japan. Ther Apher Dial 2012;16:226-31.
13. Esteve J, Benhamou E, Raymond L. Techniques for the analysis of cancer risk. In: Esteve J, Benhamou E, Raymond L, eds. Statistical Methods In Cancer Research: Volume IV: Descriptive Epidemiology. Lyon: International Agency for Research on Cancer, 1994; 49-105.
14. Richardus JH, Kunst AE. Black-white differences in infectious disease mortality in the United States. Am J Public Health 2001;91:1251-3.
15. Takeda K, Harada A, Okuda S etal. Sudden death in chronic dialysis patients. Nephrol Dial Transplant 1997;12:952-5.
16. World Health Organization. SUPRE. 2012. [Accessed 1 Jun 2009.] Available from URL: http://www.who.int/mental_health/prevention/suicide/supresuicideprevent/en/
17. Kurella M, Kimmel PL, Young BS etal. Suicide in the United States end-stage renal disease program. J Am Soc Nephrol 2005;16:774-81.
18. Fukuhara S, Green J, Albert J etal. Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan. Kidney Int 2006;70:1866-72.
19. Fabrizi F, Takkouche B, Lunghi G etal. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat 2007;14:697-703.
20. Nakayama E, Akiba T, Marumo F etal. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000;11:1896-902.
21. Espinosa M, Martin-Malo A, Alvarez de Lara MA etal. Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 2001;16:1669-74.
22. Nangaku M, Akizawa T. Diary of a Japanese nephrologist during the present disaster. Kidney Int 2011;79:1037-9.
23. Kazama JJ, Narita I. Earthquake in Japan. Lancet 2011;377:1652-3.
24. Perneger TV, Klag MJ, Whelton PK. Cause of death in patients with end-stage renal disease: death certificates vs registry reports. Am J Public Health 1993;83:1735-8.
25. Li SQ, Cass A, Cunningham J. Cause of death in patients with end-stage renal disease: assessing concordance of death certificates with registry reports. Aust N Z J Public Health 2003;27:419-24.